Tag: Pharmaceutical industry
Eli Lilly Joins Lawsuit on Compounded Drugs
Eli Lilly Joins Lawsuit on Compounded Drugs In a recent legal development, pharmaceutical giant Eli Lilly has made a significant move by seeking to join a lawsuit on compounded drugs. This decision comes after a...
Lilly CEO’s Big Payday and Olympics Treat
Lilly CEO’s Big Payday and Olympics Treat In the world of biotech, where science and politics intersect, there are always intriguing developments that capture the attention of industry insiders and the general public alike. Today,...
Next-Gen Obesity Drug Disappoints: Novo Nordisk Shares Drop
Novo Nordisk, a pharmaceutical giant, recently experienced a setback that sent shockwaves through the industry. The company's highly anticipated next-generation obesity drug, CagriSema, failed to meet investors' expectations, resulting in a significant drop in...
Critics question transparency as U.K. trade group lifts Novo Nordisk suspension
A U.K. trade group is preparing to lift a two-year suspension of Novo Nordisk due to "serious breaches" in promoting an obesity drug. The suspension, which was issued on March 16, 2023, by the...
Compounding Group Faces Legal Setback; Hims Stock Declines
A legal setback for a compounding group has caused a decline in Hims stock, stirring up the biotech industry. The ruling against the Outsourcing Facility Association, a compounding trade group, has impacted the production...
Pfizer and GSK DEI Changes, Pharma Tariffs: Pharmalittle News
Pfizer and GSK Make DEI Changes Amid Pharma Tariffs: A Look into Industry Transformations As another workweek comes to a close, the anticipation of weekend plans fills the air with promise. The prospect of catching...
Drugmakers’ Wish List: Meeting Trump’s Expectations in Healthcare
In a bold move that could potentially impact the entire pharmaceutical industry, Eli Lilly's CEO, Dave Ricks, recently announced plans to construct four manufacturing sites in the United States. This significant $27 billion investment...
Bill in Congress to Eliminate Small vs Large Molecule Drug Distinctions
In a recent development in Congress, lawmakers have put forth a bill aimed at amending a crucial aspect of the Inflation Reduction Act due to concerns that the current law is hindering investments in...
End of Novo Nordisk Ozempic and Wegovy Shortage
The Food and Drug Administration has officially announced the end of the shortage of Novo Nordisk’s popular drug semaglutide, a development that has significant implications for both patients and the pharmaceutical industry. This drug,...
Pfizer CEO Bourla’s Awkward Washington Encounter
Pfizer CEO Bourla's Awkward Washington Encounter Bluebird Bio, a biotech company, recently made headlines by avoiding bankruptcy through a strategic sale to investment firms Carlyle and SK Capital. The deal, valued at less than $30...
